1 week Ago By ABMN Staff
Trexquant Investment LP decreased its position in Ultralife Co. ( NASDAQ:ULBI – Free Report ) by 14.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
The firm owned 43,708 shares of the technology company’s stock after selling 7,125 shares during the quarter. Trexquant Investment LP owned 0.26% of Ultralife worth $326,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of the company. IFP Advisors Inc acquired a new position in Ultralife during the 4th quarter worth about $85,000. Barclays PLC lifted its position in shares of Ultralife by 21.
3% during the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock worth $121,000 after purchasing an additional 2,355 shares in the last quarter. Jane Street Group LLC purchased a new position in shares of Ultralife in the third quarter valued at approximately $166,000.
Bank of New York Mellon Corp grew its holdings in shares of Ultralife by 35.7% in the fourth quarter. Bank of New York Mellon Corp now owns 43,541 shares of the technology company’s stock valued at $324,000 after purchasing an additional 11,448 shares in the last quarter.
Finally, JPMorgan Chase & Co. grew its holdings in shares of Ultralife by 250.8% in the third quarter.
JPMorgan Chase & Co. now owns 47,458 shares of the technology company’s stock valued at $429,000 after purchasing an additional 33,929 shares in the last quarter. 30.
68% of the stock is currently owned by hedge funds and other institutional investors. Wall Street Analyst Weigh In Separately, StockNews.com cut shares of Ultralife from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th.
Ultralife Price Performance Shares of NASDAQ ULBI opened at $4.72 on Monday. The stock’s 50-day moving average is $5.
92 and its two-hundred day moving average is $7.33. The company has a debt-to-equity ratio of 0.
04, a current ratio of 3.30 and a quick ratio of 1.62.
The company has a market cap of $78.51 million, a price-to-earnings ratio of 8.58 and a beta of 0.
96. Ultralife Co. has a 1-year low of $4.
20 and a 1-year high of $13.39. Ultralife ( NASDAQ:ULBI – Get Free Report ) last issued its earnings results on Tuesday, April 1st.
The technology company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.
14). Ultralife had a net margin of 5.44% and a return on equity of 7.
92%. The firm had revenue of $43.85 million during the quarter, compared to analyst estimates of $40.
00 million. During the same period last year, the business earned $0.18 EPS.
About Ultralife ( Free Report ) Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter ..
